Literature DB >> 11606233

Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes.

S M Murta1, W G dos Santos, C Anacleto, P Nirdé, E S Moreira, A J Romanha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606233     DOI: 10.1016/s0166-6851(01)00350-4

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  12 in total

1.  Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.

Authors:  Charles Anacleto; Maria C B Abdo; Adlane V B Ferreira; Silvane M F Murta; Alvaro J Romanha; Ana Paula Fernandes; Elizabeth S A Moreira
Journal:  Parasitol Res       Date:  2003-02-11       Impact factor: 2.289

2.  Cell structure and cytokinesis alterations in multidrug-resistant Leishmania (Leishmania) amazonensis.

Authors:  V M Borges; U G Lopes; W De Souza; M A Vannier-Santos
Journal:  Parasitol Res       Date:  2004-12-10       Impact factor: 2.289

3.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

4.  Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.

Authors:  Fernanda Karoline Vieira da Silva Torchelsen; Thaila Martins Silva; Matheus Marques Milagre; Rafael Rodrigues Silva; Levi Eduardo Soares Reis; Renata Tupinambá Branquinho; Glenda Nicioli Silva; Marta de Lana
Journal:  Parasitol Res       Date:  2020-11-24       Impact factor: 2.289

5.  Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues.

Authors:  Rodrigo P Soares; Ana C Torrecilhas; Rafael R Assis; Marcele N Rocha; Felipe A Moura e Castro; Gustavo F Freitas; Silvane M Murta; Sara L Santos; Alexandre F Marques; Igor C Almeida; Alvaro J Romanha
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

6.  Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites.

Authors:  Diana Villarreal; Philippe Nirdé; Mallorie Hide; Christian Barnabé; Michel Tibayrenc
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor.

Authors:  Juan P Rigalli; Virginia G Perdomo; Marcelo G Luquita; Silvina S M Villanueva; Agostina Arias; Dirk Theile; Johanna Weiss; Aldo D Mottino; María L Ruiz; Viviana A Catania
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

8.  A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole.

Authors:  Bianca Zingales; Rafael Gomes Aquino Araujo; Margoth Moreno; Jaques Franco; Pedro Henrique Nascimento Aguiar; Solange Lessa Nunes; Marcelo Nunes Silva; Susan Ienne; Carlos Renato Machado; Adeilton Brandão
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-04-28       Impact factor: 2.743

9.  P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance.

Authors:  Mônica Caroline Oliveira Campos; Denise Barçante Castro-Pinto; Grazielle Alves Ribeiro; Márcia Moreira Berredo-Pinho; Leonardo Henrique Ferreira Gomes; Myrtes Santos da Silva Bellieny; Carla Marins Goulart; Aurea Echevarria; Leonor Laura Leon
Journal:  Parasitol Res       Date:  2013-04-10       Impact factor: 2.289

10.  Molecular characterization of the MRPA transporter and antimony uptake in four New World Leishmania spp. susceptible and resistant to antimony.

Authors:  Douglas S Moreira; Rubens L Monte Neto; Juvana M Andrade; Ana Maria M Santi; Priscila G Reis; Frédéric Frézard; Silvane M F Murta
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-09-05       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.